Huiping Chen

ORCID: 0000-0003-0308-7415
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Nanoplatforms for cancer theranostics
  • Phagocytosis and Immune Regulation
  • Epigenetics and DNA Methylation
  • Ferroptosis and cancer prognosis
  • Cancer, Lipids, and Metabolism
  • Immune Cell Function and Interaction

Sun Yat-sen Memorial Hospital
2023-2024

Sun Yat-sen University
2023-2024

Guangzhou Regenerative Medicine and Health Guangdong Laboratory
2023

Abstract The therapeutic efficacy of chemotherapy is in part a result its ability to enhance adaptive antitumor immune responses. However, tumor cells exploit various evasion mechanisms escape the attack and blunt chemosensitivity. Herein, we report that through single-cell profiling microenvironment, identified subset CD161-overexpressing CD8+ T enriched chemoresistant tumors. CD161 engagement repressed calcium influx cytolytic capacity acid sphingomyelinase activation ceramide generation....

10.1158/2326-6066.cir-22-0356 article EN cc-by-nc-nd Cancer Immunology Research 2023-01-05

<div>Abstract<p>The therapeutic efficacy of chemotherapy is in part a result its ability to enhance adaptive antitumor immune responses. However, tumor cells exploit various evasion mechanisms escape the attack and blunt chemosensitivity. Herein, we report that through single-cell profiling microenvironment, identified subset CD161-overexpressing CD8<sup>+</sup> T enriched chemoresistant tumors. CD161 engagement repressed calcium influx cytolytic capacity acid...

10.1158/2326-6066.c.6551199 preprint EN 2023-04-04

<div>Abstract<p>The therapeutic efficacy of chemotherapy is in part a result its ability to enhance adaptive antitumor immune responses. However, tumor cells exploit various evasion mechanisms escape the attack and blunt chemosensitivity. Herein, we report that through single-cell profiling microenvironment, identified subset CD161-overexpressing CD8<sup>+</sup> T enriched chemoresistant tumors. CD161 engagement repressed calcium influx cytolytic capacity acid...

10.1158/2326-6066.c.6551199.v1 preprint EN 2023-04-04
Coming Soon ...